NCT03126409

Brief Summary

This study evaluates the short-term patency of vein graft harvested by the No-Touch technique compared to that by the conventional approach in patients undergoing isolated on-pump/off-pump coronary artery bypass graft (CABG) surgery. a total of at least 2000 patients undergoing isolated on-pump/off-pump CABG will be consecutively recruited from 7 hospitals across China and randomly assigned to receive No-Touch saphenous vein harvesting or conventional approach. All participants will be invited for clinical follow-up and 64-slice multislice computed tomography angiography (MSCTA) analysis at 3 months post-operatively.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,655

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
45mo left

Started May 2017

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
May 2017Dec 2029

First Submitted

Initial submission to the registry

April 19, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2017

Completed
20 days until next milestone

Study Start

First participant enrolled

May 14, 2017

Completed
12.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2029

Last Updated

October 4, 2024

Status Verified

October 1, 2024

Enrollment Period

12.6 years

First QC Date

April 19, 2017

Last Update Submit

October 3, 2024

Conditions

Keywords

coronary artery diseasecoronary artery bypass graft

Outcome Measures

Primary Outcomes (1)

  • Prevalence of graft occlusion

    All participants will be invited to return to their operating hospitals for 64-slice multi-slice computed tomography angiography to determine patencies of the graft vessels.

    3 month after procedure

Secondary Outcomes (8)

  • Prevalence of graft occlusion

    1, 3, 5, 7, and 10 years after procedure

  • Overall major adverse cardiac or cerebrovascular events (MACCE) rate

    3 month , 1, 3, 5, 7, and 10 years after procedure

  • Cardiac death

    3 month , 1, 3, 5, 7, and 10 years after procedure

  • Documented non-lethal myocardial infarction

    3 month , 1, 3, 5, 7, and 10 years after procedure

  • Stroke

    3 month , 1, 3, 5, 7, and 10 years after procedure

  • +3 more secondary outcomes

Study Arms (2)

No-Touch vein harvesting technique

EXPERIMENTAL

During saphenous vein harvesting, surrounding tissue of the vein is preserved, and manual distension of the vein graft is avoided

Procedure: No-Touch vein harvesting technique

Conventional vein harvesting

ACTIVE COMPARATOR

During saphenous vein harvesting, surrounding tissue of the vein is stripped off, and manual distension is routinely performed

Procedure: Conventional vein harvesting

Interventions

The No-Touch technique focuses on saphenous vein graft harvesting, featured by preserving the surrounding tissue of the vein while at the same time avoiding manual distension.

No-Touch vein harvesting technique

During saphenous vein harvesting, surrounding tissue of the vein is stripped off, and manual distension is routinely performed

Conventional vein harvesting

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving first time isolated on-pump/off-pump CABG
  • Patients with at least one available saphenous vein graft

You may not qualify if:

  • Need for a concomitant cardiac or vascular surgeries (i.e. valve repair or replacement, Maze surgery)
  • Redo-CABG
  • Emergent CABG
  • Using vascular stapler for anastomosis
  • Endarterectomy of coronary artery during surgery
  • Left ventricular repair due to ventricular aneurysm
  • Combined with malignant tumor or other severe systemic conditions
  • Severe renal insufficiency (i.e. creatinine \>200 μmol/L)
  • Contraindications for dual antiplatelet therapy, such as active gastroduodenal ulcer
  • Participants of another ongoing clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, 100037, China

Location

Related Publications (3)

  • Wang X, Tian M, Zheng Z, Gao H, Wang Y, Wang L, Hu S. Rationale and design of a multicenter randomized trial to compare the graft patency between no-touch vein harvesting technique and conventional approach in coronary artery bypass graft surgery. Am Heart J. 2019 Apr;210:75-80. doi: 10.1016/j.ahj.2018.11.011. Epub 2018 Dec 6.

    PMID: 30743210BACKGROUND
  • Tian M, Wang X, Feng W, Wang H, Liu S, Liu Z, Chen Y, Miao Q, Su P, Li X, Wang Y, Lu B, Chen K, Zhang C, Hu S. No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial. BMJ. 2025 Apr 30;389:e082883. doi: 10.1136/bmj-2024-082883.

  • Tian M, Wang X, Sun H, Feng W, Song Y, Lu F, Wang L, Wang Y, Xu B, Wang H, Liu S, Liu Z, Chen Y, Miao Q, Su P, Yang Y, Guo S, Lu B, Sun Z, Liu K, Zhang C, Wu Y, Xu H, Zhao W, Han C, Zhou X, Wang E, Huo X, Hu S. No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial. Circulation. 2021 Oct 5;144(14):1120-1129. doi: 10.1161/CIRCULATIONAHA.121.055525. Epub 2021 Sep 13.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2017

First Posted

April 24, 2017

Study Start

May 14, 2017

Primary Completion (Estimated)

December 30, 2029

Study Completion (Estimated)

December 30, 2029

Last Updated

October 4, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations